FDA
approval
· 2019-03-04
FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (AvKARE)
Summary
The FDA approved AvKARE's generic fixed-dose combination of telmisartan and hydrochlorothiazide for the treatment of hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)